Call Us + 33 1 84 88 31 00

Article R5121-138-3 of the French Public Health Code

All medicinal products are fitted with the tamper-evident device referred to in Article R. 5121-138-2. However, this device is not compulsory for medicinal products on the list set out in Annex I to Commission Delegated Regulation No 2016/161 EU of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by laying down detailed rules concerning safety features on the packaging of medicinal products for human use.

Original in French 🇫🇷
Article R5121-138-3

Tous les médicaments sont dotés du dispositif antieffraction mentionné à l’article R. 5121-138-2. Toutefois, ce dispositif n’est pas obligatoire pour les médicaments présents sur la liste établie à l’annexe I du règlement délégué n° 2016/161 UE de la Commission du 2 octobre 2015 complétant la directive 2001/83/ CE du Parlement européen et du Conseil en fixant les modalités des dispositifs de sécurité figurant sur l’emballage des médicaments à usage humain.

Need help with this article? Get help from a French lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.